Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05488119 · ClinicalTrials.gov registry record · NA

BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes

A NA study of Type 1 Diabetes, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05488119 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Stanford University. The registered enrollment target is 20 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05488119, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Youth with public insurance underutilize diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, we urgently need studies to understand and increase diabetes technology utilization. This proposed research will (1) improve representation of youth in the literature, (2) address the gap in knowledge of barriers and promoters in youth, and (3) identify and address factors associated with diabetes technology uptake and utilization.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention to increase diabetes technology uptake

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-04-15
Est. Completion 2026-06-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05488119

The ClinicalTrials.gov registry entry for NCT05488119 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Intervention to increase diabetes technology uptake is the first listed.

NCT05488119 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05488119 about?

NCT05488119 is a clinical study titled "BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes". Youth with public insurance underutilize diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, we urgently need studies to understand and increase diabetes technology utilization. This proposed research will (1) improve representati...

What is the current status of trial NCT05488119?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-04-15. Estimated completion is 2026-06-30.

What conditions does trial NCT05488119 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT05488119?

The interventions under investigation include: Intervention to increase diabetes technology uptake (BEHAVIORAL).

Who is sponsoring clinical trial NCT05488119?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05488119 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.